News | December 30, 2013

ProCure Proton Centers Select RayStation for Proton Planning

raysearch raystation proton radiation therapy treatment planning systems procure
December 30, 2013 — RaySearch Laboratories AB received two orders for its RayStation treatment planning system from the proton treatment centers Seattle ProCure Management LLC, Seattle, and Princeton ProCure Management LLC, Princeton, N.J. The two centers will use RayStation for treatment planning of proton radiation therapy.
 
“There are several reasons why we selected RayStation,” said Tony Wong, director of physics, Seattle ProCure Treatment Center, and Dennis Mah, director of physics, New Jersey ProCure Treatment Center. “The most important benefits are the breadth of technology, high speed of planning and dose computation and ease of analysis compared to other modalities. This is the best system currently available in terms of robust optimization, computational accuracy and ease of use.”
 
“ProCure is a well-known name in proton therapy, and given the strong partnerships between RaySearch, IBA and now Procure, we are confident that this is a big step forward for all of us and how proton planning can evolve,” said Marc Mlyn, president, RaySearch Americas.
 
The current version of RayStation that has U.S. Food and Drug Administration (FDA) clearance supports the proton treatment techniques Uniform Scanning and Double Scattering. Support for pencil beam scanning (PBS) / intensity-modulated proton therapy (IMPT) has been released in Europe with CE marking and 510(k) clearance in the United States for PBS is expected early 2014.
 
For more information: www.raysearchlabs.com

Related Content

RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Feature | Treatment Planning | July 03, 2018 | By Jeff Zagoudis
A new software developed and recently tested at the MD Anderson Cancer Center demonstrated the ability to largely aut
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Overlay Init